Boston, MA -- (SBWIRE) -- 09/13/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Stemline Therapeutics Inc (NASDAQ:STML), iRobot Corporation (NASDAQ:IRBT), Chimerix Inc (NASDAQ:CMRX), KEYW Holding Corp. (NASDAQ:KEYW)
Stemline Therapeutics Inc (NASDAQ:STML) stock jumped 3.54% to $37.77. Research analysts at Wedbush initiated coverage on shares of STML in a report released on Sept. 11. The firm set an “outperform” rating and a $49.00 price target on the stock. Separately, analysts at Jefferies Group initiated coverage on shares of STML in a research note to investors on August 29. They set a “buy” rating and a $60.00 price target on the stock.
How Should Investors Trade STML After The Recent Volatility? Get Free Report Here
iRobot Corporation (NASDAQ:IRBT) stock climbed 3.45% to $37.48. Analysts at Susquehanna assumed coverage on shares of IRBT in a research report issued to clients and investors on Sept. 9. The firm set a “positive” rating on the stock.
Additionally, the company on Sept. 6 obtained preliminary injunctions against Chinese companies Shenzhen Silver Star Intelligent Technology Co., Ltd and Shenzhen Silver Star Intelligent Electronic Ltd. (together: "Shenzhen Silver Star") with the District Court of Düsseldorf. The request was based on the German parts of four European patents, EP 1 331 537 B1, EP 2 251 757 B1, EP 1 969 438 B1, and EP 1 395 888 B1.
How Should Investors Trade IRBT After The Recent Volatility? Get Free Report Here
Chimerix Inc (NASDAQ:CMRX) shares climbed 3.43% and closed at $18.41. The company on Sept. 11 said its experimental drug failed to show significant benefit in a mid-stage study involving a type of viral infection that mainly affects the lungs. The drug, brincidofovir, was being tested on 48 patients with blood and bone marrow cancers who had adenovirus infection (AdV), a potentially fatal condition which has no known approved treatments. The trial was designed to evaluate the potential to decrease the viral infection or prevent its progression. The drug was given to patients once or twice a week.
Is CMRX A Good Buy After The Recent Price Movement? Find Out Here
KEYW Holding Corp. (NASDAQ:KEYW) shares jumped 3.40% and closed at $13.07 in the last trading session. Hexis Cyber Solutions, Inc. (Hexis), a subsidiary of The KEYW Corporation (Nasdaq:KEYW), on Sept. 10 announced its EMEA Exchange 2013 conference will be held October 15-17, 2013 at the Athenaeum Athens Intercontinental Hotel in Athens, Greece. Attendees will have the opportunity to participate in a knowledge exchange of the latest enterprise security topics through expert led business and technology forums, hands-on sessions, and training. Such topics will include: emerging cybersecurity threats, big data management, advanced analytics, government regulation & compliance, and data retention challenges & solutions.
Is KEYW A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)